1. Home
  2. JXJT vs HUGE Comparison

JXJT vs HUGE Comparison

Compare JXJT & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXJT
  • HUGE
  • Stock Information
  • Founded
  • JXJT 2012
  • HUGE 1998
  • Country
  • JXJT China
  • HUGE Canada
  • Employees
  • JXJT N/A
  • HUGE N/A
  • Industry
  • JXJT Apparel
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • JXJT Consumer Staples
  • HUGE Health Care
  • Exchange
  • JXJT Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • JXJT 8.1M
  • HUGE 7.8M
  • IPO Year
  • JXJT 2012
  • HUGE N/A
  • Fundamental
  • Price
  • JXJT $1.34
  • HUGE $0.14
  • Analyst Decision
  • JXJT
  • HUGE
  • Analyst Count
  • JXJT 0
  • HUGE 0
  • Target Price
  • JXJT N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • JXJT 663.1K
  • HUGE 2.5M
  • Earning Date
  • JXJT 08-14-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • JXJT N/A
  • HUGE N/A
  • EPS Growth
  • JXJT N/A
  • HUGE N/A
  • EPS
  • JXJT 0.48
  • HUGE N/A
  • Revenue
  • JXJT $31,840,588.00
  • HUGE N/A
  • Revenue This Year
  • JXJT N/A
  • HUGE N/A
  • Revenue Next Year
  • JXJT N/A
  • HUGE N/A
  • P/E Ratio
  • JXJT $2.78
  • HUGE N/A
  • Revenue Growth
  • JXJT N/A
  • HUGE N/A
  • 52 Week Low
  • JXJT $1.04
  • HUGE $0.13
  • 52 Week High
  • JXJT $8.51
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • JXJT 54.99
  • HUGE 29.78
  • Support Level
  • JXJT $1.20
  • HUGE $0.14
  • Resistance Level
  • JXJT $1.33
  • HUGE $0.16
  • Average True Range (ATR)
  • JXJT 0.23
  • HUGE 0.02
  • MACD
  • JXJT -0.00
  • HUGE 0.01
  • Stochastic Oscillator
  • JXJT 26.44
  • HUGE 24.41

About JXJT JX Luxventure Limited

JX Luxventure Ltd is engaged in the business of menswear, cross-border merchandise, airfare, and tourism. The company operates in three segments Tourism products, Technology and Cross- board merchandise. The majority of the group revenue is generated from the Tourism products.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: